Cargando…
Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis
BACKGROUND: Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially in adolescents and adults, has increased in sev...
Autores principales: | Han, Hyun-Ja, Kuwae, Asaomi, Abe, Akio, Arakawa, Yoshichika, Kamachi, Kazunari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053399/ https://www.ncbi.nlm.nih.gov/pubmed/21423776 http://dx.doi.org/10.1371/journal.pone.0017797 |
Ejemplares similares
-
Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue
por: Bayram, Jan, et al.
Publicado: (2020) -
BteA Secreted from the Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton Signaling Pathway and Inhibits Phagocytosis by Macrophages
por: Kuwae, Asaomi, et al.
Publicado: (2016) -
Correction: BteA Secreted from the Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton Signaling Pathway and Inhibits Phagocytosis by Macrophages
por: Kuwae, Asaomi, et al.
Publicado: (2017) -
Characterization of the N-Terminal Domain of BteA: A Bordetella Type III Secreted Cytotoxic Effector
por: Guttman, Chen, et al.
Publicado: (2013) -
Lipid binding by the N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA
por: Malcova, Ivana, et al.
Publicado: (2021)